Abstract: Objective:To analyze the clinical prognostic factors of liposarcoma on the extremities and trunk, as well as to retrospectively analyze the effect of adjuvant radiotherapy and chemotherapy on liposarcoma of the extremities. Methods:Patients with liposarcoma of the extremities treated in our hospital from July 1, 2007 to December 31 , 2012 were followed up. The relationship of clinical prognostic factors with gender, age, location, depth, and size of the tumors, as well as the histological grade and admission status, were statistically analyzed. The effects of adjuvant radiotherapy or chemotherapy on overall survival (OS) and disease free survival (DFS) were evaluated.Results:A total of 82patients with extremity liposarcoma received surgery-based comprehensive treatment in our hospital. Of the total patients,73 received a24 -month to 88 -month satisfied follow-up; the median follow-up time was 47 months. The OS rate was83 .6% (61 /73 ), and the DFS rate was68 .5% (50 /73 ). Multivariate Cox regression analysis showed that the tumor location, histological grade, and admission status were the independent correlative factors influencing DFS, and the age and pathologic grading were the independent correlative factors influencing the OS. Kaplan-Meier survival analysis showed that radiation therapy can significantly improve the DFS and OS of the G2 and G3-grade liposarcoma (DFS: 59 .1 months vs . 28 .4 months,P<0.01 ; OS: 70 .8 months vs . 55 .1 months,P<0.05 ). Significant difference was not found in the effect of chemotherapy on OS and DFS. Conclusion:The prognosis of liposarcoma was significantly associated with the pathologic grades and subtypes. Auxiliary radiotherapy could improve the survival and prognosis of G 2 and G3
liposarcoma of the extremities, but the role of chemotherapy in treating liposarcoma remained unclear.